Capital Flow Monitor · Sponsors · CIK 2156954
Uvantis Therapeutics, Inc.
10980 GRANTCHESTER WAY, COLUMBIA, MD, 21044 · 6174176695
Biotechnology · Corporation· inc. DELAWARE true 2025
Fit score
—
Offering
$5.0M
Sold
$100K
% sold
2.0%
Investors
1
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-09-23 | D ·current | 506(b) | $5.0M | $100K | 2.0% | 1 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
William Sheahan — Director, Columbia, MD
1 other raise
- Auxira Health, Inc. $7.8M of $7.8M · 100.0%
-
Jonathan Young — Director, Columbia, MD
3 other raises
-
Edward Woo — Director, Columbia, MD
1 other raise
- ZeroStack Corp. $1.0B of $1.0B · 100.0%
- Paul Giannasca — Executive Officer, Columbia, MD
- Jeffrey Collins — Executive Officer, Columbia, MD
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.